Psychedelics, particularly psilocybin from mushrooms, are emerging as a promising treatment for major depression. Recent studies indicate that a single high dose can lead to significant and sustainable improvements in depressive symptoms. Experts believe these substances may revolutionize the approach to mood disorders, PTSD, and substance abuse, marking a notable shift in psychiatric treatment over the past few decades.
